ProPhase Labs, Inc. (PRPH)
OTCMKTS · Delayed Price · Currency is USD
0.0871
+0.0064 (7.98%)
At close: Mar 20, 2026
ProPhase Labs Market Cap
ProPhase Labs has a market cap or net worth of $450.05 thousand as of March 20, 2026. Its market cap has decreased by -96.35% in one year.
Market Cap
450.05K
Enterprise Value
7.73M
Revenue
5.06M
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.09
Market Cap Chart
Since January 2, 1996, ProPhase Labs's market cap has decreased from 5.04M to 450.05K, a decrease of -91.07%. That is a compound annual growth rate of -7.68%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 20, 2026 | 450.05K | -78.22% |
| Dec 31, 2025 | 2.07M | -88.57% |
| Dec 31, 2024 | 18.08M | -77.84% |
| Dec 29, 2023 | 81.56M | -47.97% |
| Dec 30, 2022 | 156.75M | 41.18% |
| Dec 31, 2021 | 111.03M | 4.23% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Aspira Women's Health | 14.36M |
| Psychemedics | 8.44M |
| Stella Diagnostics | 4.82M |
| Hypha Labs | 4.06M |
| Centogene | 3.59M |
| InVitro International | 1.98M |
| IDenta | 1.00M |
| NovelStem International | 468.82K |